Cigall Kadoch

Dr. Cigall Kadoch is a scientific advisor for Nested Therapeutics. She is an Associate Professor of Pediatric Oncology at the Dana-Farber Cancer Institute and Harvard Medical School, Institute Member and Epigenomics Program Co-Director at the Broad Institute of MIT and Harvard, and Investigator of the Howard Hughes Medical Institute. She is also the Scientific Founder of Foghorn Therapeutics (NASDAQ: FHTX). She established her independent laboratory in 2014, and was one of the youngest scientists ever appointed to the Harvard Medical School faculty at the age of 28. She has quickly become a leading expert in chromatin and gene regulation and is internationally recognized for her groundbreaking studies in these areas. Specifically, her laboratory studies the structure and function of nuclear protein complexes that govern DNA architecture and gene expression, known as chromatin remodeling complexes, perturbations in which cause a range of human cancers and neurodevelopmental disorders. Her work has catalyzed the development of several ongoing therapeutic development programs aimed to target a range of human diseases.